Between ONC's push for algorithm transparency, FDA's PCCP path for learning devices, and the EU AI Act's phased obligations, buyers aren't asking for magic—they're asking for traceable impact, grounded data, and explainable decisions.
At Conult Health Analytics, we're leaning in:
Our Approach
Grounded predictions that cite their data (claims + EMR + SDoH) and show why a patient is rising-risk—so clinicians can act with confidence.
Virtual-simulation insights to compare a member's likely course with clinically similar peers and surface the 2–3 highest-leverage interventions.
Interoperable by design (FHIR/TEFCA-friendly), with fairness audits and change-control baked into the MLOps stack.
Outcome focus—think avoidable ED use, LOS, readmissions, and risk capture accuracy—because in value-based care, results beat rhetoric.
Why Now?
Regulatory tailwinds are aligning transparency and safety with clinical workflow—this rewards grounded analytics over black boxes.
Market signal: health systems and risk-bearing orgs are prioritizing tools that reduce avoidable costs and protect benchmarks.
Macro growth: healthcare analytics is scaling fast, but differentiation now lives in explainability, interoperability, and time-to-value.
The Bottom Line
If you're leading care management, pop health, or value-based operations and want a 6-week pilot laser-focused on ED/unplanned admissions, let's talk.
The era of "trust us, it's AI" is over. The era of "here's exactly how we got there, and here's the impact" has begun.